Therma Bright (TSE:THRM) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Therma Bright has signed a letter of intent with DME Authority to expand the U.S. distribution of its Venowave VW5 devices, targeting a $6 million inventory purchase within the first half of 2025. This partnership aims to enhance patient access to the mobile mechanical compression solution across multiple healthcare channels.
For further insights into TSE:THRM stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
- “The No. 1 Destination for the Most Talented Artists”: Netflix Stock (NASDAQ:NFLX) Notches Up as the Duffer Brothers Consider Jumping Ship
- “Breakthrough EVs”: Ford Stock (NYSE:F) Notches Up on New Battery Details
- “An Equity Stake”: Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money